BioPharma Bitez: Verona, Aptinyx, and more!

Happy Friday everybody, welcome to this week’s edition of “BioPharma Bitez.” Top news in the industry as well as one story outside of it. Now, with a new, shinier, backdrop! So, to kick it off this week, Verona suffered a “phase two failure” for a COPD bronchodilator product. It would… Read more

BioPharma Bitez: Novartis, Takeda and more!

Happy Friday everybody, welcome to this week’s edition of “BioPharma Bitez.” The tops news in the industry as well as one story outside of it. So, obviously, J.P. Morgan was this week, so, some of the stories that came out of that: Eli Lilly has bought Loxo for 8 billion… Read more

BioPharma Bitez: GSK, Vanda, Abbvie, and more!

Happy Friday everybody! Welcome to this week’s edition of “BioPharma Bitez”, the top news of the industry as well as one outside of it. So, to kick it off this week, the obvious story is GSK buying Tesaro for 5 billion dollars. This will actually expand GSK’s commercial oncology portfolio. We… Read more

The Value of Trade shows

 I wanted to continue the discussion with effective marketing strategies. All of these tips should be used in tandem. So, we’ve got “MPC marketing” finding those impact players, critically important. Building your brand through social media, doing a post, just getting active in those areas. Do more today than… Read more

BioPharma Bitez: Nestle, Moderna, and Stan Lee

Happy Friday everybody. Welcome to this week’s edition of “BioPharma Bitez.” Top news in the industry as well as one story outside of it. So, to kick it off this week, Nestle has increased their stake in Aimmune’s Peanut Allergy medication portfolio up to 276 million dollars with their investment.… Read more

BioPharma Bitez: AstraZeneca, Biogen, and more!

Happy Friday everybody, welcome to this week’s episode of “BioPharma Bitez,” the top news of the industry, as well as one interesting story outside of it. So, to kick it off, Bain Capital announced this week they’re going to back a start-up called “Cerevel” which is a neuroscience-based pipeline that… Read more

Interviewing and Resume Strategies

Good morning guys, my name is Hannah. I am a search consultant here at Govig and Associates. And, today I wanted to share a few tips for people who are considering a new role, or, are interviewing for a new opportunity. I wanted to share a strategy for answering interview questions.… Read more

Why You Should Speak to a Recruiter

Hi, my name is Jacob Harris, and I am TJ Decker. We’re executive recruiters at Govig and Associates, and we’re specialized in the commercial interior space nationally. Today we wanted to talk to you about the importance of taking a recruiters call, and how the purpose of our call, is… Read more

What Candidates Tell Recruiters

Hi, my name is Jessica Penney and I am an executive recruiter here at Govig and Associates. I specialize in the building products industry, especially working closely with window and door companies, nationwide. Today, I wanted to talk to you about what candidates tell recruiters, that they do not typically… Read more

How to Leverage Social Media

Hi, my name is Neil Hefta, vice president with Govig Healthcare Group. I have been an executive recruiter since 1998 actually worked in the nursing home industry as an administrator. And today I wanted to share a fun video from a recruiters perspective of 20 years on the value of LinkedIn.… Read more